Currently funded projects

Immunooncology and local interventions (IOLIN)
Institution: Klinikum der Ludwig-Maximilians-Universität München
Applicants: Prof. Dr. Sebastian Kobold (Speaker), Prof. Dr. Kirsten Lauber (deputy speaker), Prof. Dr. Dr. Michael von Bergwelt (deputy speaker)
EKFS funding line: Else Kröner Research Schools for Physicians

iPRIME - Clinician Scientist
Institution: University Medical Center Hamburg-Eppendorf (UKE)
Applicants Prof. Dr. Tobias B. Huber (Speaker) , Prof. Dr. Ulf Panzer (Speaker)
EKFS funding line: Else Kröner Research Schools for Physicians

Impact of antigen recognition and immunosuppression on pathogen-specific follicular T helper cells
Institution: Department of Internal Medicine II, University Hospital Freiburg
Applicant: Tobias Böttler
EKFS funding line: Else Kröner Excellence Fellowships

Overcoming dysfunctional immune responses in chronic HPV/ HIV infection: a way to cure
Institution: Department of Infectious Diseases, Medizinische Klinik IV, LMU University Hospital
Applicants: PD Dr. Julia Roider
EKFS funding line: First Applications

CHIKAmark – Biomarkers for severe Chikungunya virus infections
Institution: Institute of Virology, Charité – Universitätsmedizin Berlin
Applicants: Jan Felix Drexler / Carlo Fischer
EKFS funding line: Key Projects

Dissecting the human T cell receptor-epitope interaction landscape through artificial intelligence guided analysis of antigen-specific T cell responses after yellow fever vaccination
Institution: Mikrobiologisches Institut - Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen und Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg
Applicant: Dr. Kilian Schober
EKFS funding line: First and Second Applications

Monogenic CD33 deficiency as cause of pediatric inflammatory bowel disease – A model to explore mechanisms and therapeutic targets for inflammatory and hematological disorders
Applicant: Dr. Daniel Kotlarz, PhD
Institution: Dr. von Hauner Children’s Hospital, Department of Pediatrics, University Hospital, Ludwig-Maximilians-Universität München
EKFS funding line: Key Project

DNA damage response by caspase-activated DNAse (CAD): a physiological process with pathophysiological potential?
Institution: Institute of Microbiology and Hygiene, Universitätsklinikum Freiburg
Applicant: Prof. Dr. Georg Häcker
EKFS funding line: Key Project

Longitudinal assessment of cerebral microstructural damage and resulting cognitive deficits in relapsing-remitting multiple sclerosis
Institution: Department of Neurology / Brain Imaging Center, Goethe University Frankfurt
Applicant: Priv.-Doz. Dr. med. René-Maxime Gracien
EKFS funding line: First and Second Applications

Type 1 Diabetes in Ghana and Germany – Immune pathology of early versus late disease onset and influencing genetic and environmental factors
Institution: Klinik für Allgemeine Pädiatrie, Neonatologie und Kinderkardiologie, Universitätsklinikum Düsseldorf
Applicant: Julia Seyfarth
EKFS funding line: first application